Profile data is unavailable for this security.
About the company
ZHEJIANGHUAHAIPHARMACEUTICALCO., LTD is a China-based company, principally engaged in the manufacture and distribution of active pharmaceutical ingredients (APIs), intermediates and preparations. The Company's main products are classified as -pril series, -sartan series and preparations, including irbesartan tablets, paroxetine hydrochloride tablets, risperidone tablets, fosinopril sodium tablets, as well as irbesartan and hydrochlorothinzide tablets, among others. The Company also provides related technical support services. The Company distributes its products in domestic and overseas markets.
- Revenue in CNY (TTM)8.75bn
- Net income in CNY928.37m
- Incorporated2001
- Employees8.22k
- LocationZhejiang Huahai Pharmaceutical Co LtdXunqiao, Linhai CityTAIZHOU 317024ChinaCHN
- Phone+86 57 685991096
- Fax+86 57 685016010
- Websitehttps://www.huahaipharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sinocelltech Group Ltd | 2.17bn | -168.81m | 22.41bn | 2.33k | -- | -- | -- | 10.32 | -0.3791 | -0.3791 | 4.88 | -1.16 | 0.761 | 0.3743 | 6.86 | 930,592.90 | -5.93 | -40.17 | -15.48 | -74.63 | 96.35 | 95.42 | -7.79 | -108.20 | 0.4649 | 3.33 | 1.23 | -- | 84.46 | 264.19 | 23.70 | -- | 37.54 | -- |
| Tasly Pharmaceutical Group Co Ltd | 8.64bn | 1.10bn | 23.66bn | 9.22k | 21.57 | 1.87 | -- | 2.74 | 0.7342 | 0.7342 | 5.77 | 8.47 | 0.4899 | 1.72 | 10.80 | 937,046.80 | 5.93 | 5.47 | 7.21 | 7.25 | 65.67 | 48.42 | 12.11 | 8.94 | 2.73 | 5.91 | 0.2083 | 50.99 | 0.4236 | -13.57 | 505.34 | -7.07 | -3.03 | 1.92 |
| Joincare Pharmaceutical Group Ind. Co. | 16.43bn | 1.42bn | 23.71bn | 14.37k | 16.55 | 1.67 | -- | 1.44 | 0.7676 | 0.7676 | 8.86 | 7.63 | 0.4522 | 2.36 | 5.57 | 1,143,551.00 | 7.98 | 8.46 | 16.51 | 18.84 | 61.23 | 62.72 | 17.64 | 17.00 | 2.11 | -- | 0.2247 | 28.86 | -2.90 | 8.24 | -3.99 | 15.58 | 11.53 | 2.38 |
| China Resources Dubl-Crne Phrmctl Co Ltd | 10.32bn | 1.38bn | 23.79bn | 12.27k | 17.05 | 2.04 | -- | 2.31 | 1.34 | 1.34 | 10.07 | 11.24 | 0.6781 | 2.85 | 5.82 | 841,054.60 | 8.87 | 8.58 | 11.67 | 11.21 | 54.25 | 58.19 | 13.08 | 11.98 | 2.15 | -- | 0.0249 | 35.91 | 6.20 | 4.44 | 12.96 | 6.60 | 21.46 | -1.63 |
| Xiamen Amoytop Biotech Co Ltd | 2.23bn | 600.08m | 23.90bn | 1.96k | 39.83 | 11.92 | -- | 10.74 | 1.48 | 1.48 | 5.47 | 4.93 | 1.04 | 0.8541 | 6.70 | 1,135,877.00 | 28.09 | 17.96 | 32.72 | 21.02 | 93.17 | 90.48 | 26.95 | 19.17 | 3.22 | -- | 0.0037 | 26.95 | 37.55 | 36.19 | 93.52 | 103.28 | 81.61 | -- |
| Zhejiang Huahai Pharmaceutical Co., Ltd. | 8.75bn | 928.37m | 26.11bn | 8.22k | 27.56 | 3.06 | -- | 2.98 | 0.6391 | 0.6391 | 6.02 | 5.76 | 0.4511 | 1.08 | 3.46 | 1,064,162.00 | 4.76 | 5.67 | 6.90 | 8.07 | 59.44 | 60.52 | 10.55 | 11.61 | 0.8451 | 5.48 | 0.5047 | 33.55 | 0.5199 | 10.28 | -28.88 | 50.51 | 7.21 | -- |
| Shanghai Junshi Biosciences Co Ltd | 1.63bn | -2.02bn | 26.20bn | 2.57k | -- | 4.42 | -- | 16.09 | -2.06 | -2.06 | 1.66 | 6.97 | 0.1348 | 1.05 | 4.11 | 634,034.10 | -18.18 | -18.87 | -23.17 | -23.11 | 64.05 | 69.13 | -134.86 | -88.41 | 1.91 | -215.80 | 0.3018 | -- | 3.38 | 248.39 | 4.38 | -- | 8.36 | -- |
| Kangmei Pharmaceutical Co Ltd | 4.93bn | 160.40m | 27.17bn | 4.41k | 168.53 | 3.83 | -- | 5.51 | 0.0116 | 0.0116 | 0.3572 | 0.5117 | 0.34 | 1.40 | 2.43 | 1,118,464.00 | 1.12 | -17.60 | 1.69 | -32.24 | 22.71 | -72.78 | 3.28 | -101.19 | 0.8746 | -- | 0.0465 | -- | 16.60 | -22.17 | 103.81 | -22.83 | -53.51 | -- |
| Bluestar Adisseo Co | 13.53bn | 327.58m | 27.22bn | 2.73k | 83.09 | 1.80 | -- | 2.01 | 0.1222 | 0.1222 | 5.04 | 5.63 | 0.6286 | 4.67 | 7.33 | 4,947,799.00 | 1.52 | 5.28 | 1.85 | 6.94 | 23.81 | 30.31 | 2.42 | 8.76 | 1.04 | 4.30 | 0.1325 | 21.81 | -9.26 | 2.92 | -95.82 | -43.75 | 2.74 | -19.09 |
| Shanghai Allist Pharmaceuticals Co Ltd | 1.62bn | 487.02m | 29.08bn | 870.00 | 59.71 | 7.97 | -- | 17.94 | 1.08 | 1.08 | 3.60 | 8.10 | 0.4513 | 1.96 | 9.77 | 1,863,318.00 | 13.56 | -6.70 | 14.46 | -7.38 | 94.94 | 96.63 | 30.04 | -49.48 | 8.50 | -- | 0.0006 | -- | 49.22 | 152.37 | 614.22 | -- | 152.72 | -- |
| Gan & Lee Pharmaceuticals | 2.61bn | 386.85m | 29.90bn | 4.48k | 74.83 | 2.74 | -- | 11.46 | 0.6726 | 0.6726 | 4.52 | 18.38 | 0.234 | 0.8926 | 10.97 | 582,412.30 | 3.47 | 8.30 | 3.71 | 8.83 | 72.29 | 85.39 | 14.83 | 26.44 | 7.74 | -- | 0.0006 | 13.65 | 52.31 | 1.78 | 177.37 | -18.30 | 1.50 | -- |
Data as of Apr 18 2024. Currency figures normalised to Zhejiang Huahai Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
7.72%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Harvest Fund Management Co., Ltd.as of 30 Jun 2023 | 23.02m | 1.58% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2023 | 18.14m | 1.25% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2023 | 11.87m | 0.82% |
| Essence Fund Co., Ltd.as of 30 Jun 2023 | 11.67m | 0.80% |
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2023 | 9.04m | 0.62% |
| Taikang Asset Management Co. Ltd.as of 30 Jun 2023 | 8.92m | 0.61% |
| Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 2023 | 7.64m | 0.53% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 7.61m | 0.52% |
| Caitong Securities Asset Management Co., Ltd.as of 30 Jun 2023 | 7.51m | 0.52% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2023 | 6.91m | 0.48% |
More ▼
Data from 30 Jun 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
